vinpocetine has been researched along with Cognitive Dysfunction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Hu, F; Nie, H; Shao, L; Xu, R; Zhang, P | 1 |
| Cao, Y; Chen, S; Shao, L; Zhang, P | 1 |
| Chang, YC; Perng, CH; Tzang, RF | 1 |
| Dan, Y; Li, C; Liu, Y; Lu, QL; Song, G; Xu, MS; Yin, Y | 1 |
| Abu-Elfotuh, K; Ahmed, HI; Ali, AA; Khaleel, SA | 1 |
| Gyuris, J | 1 |
| Csányi, A; Németh, L; Valikovics, A | 1 |
2 review(s) available for vinpocetine and Cognitive Dysfunction
| Article | Year |
|---|---|
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis.
Topics: Alzheimer Disease; Clinical Trials as Topic; Cognitive Dysfunction; Combined Modality Therapy; Complementary Therapies; Dementia; Donepezil; Ginkgo biloba; Humans; Plant Extracts; Treatment Outcome; Vinca Alkaloids | 2018 |
Vinpocetine in the treatment of poststroke cognitive dysfunction: A protocol for systematic review and meta-analysis.
Topics: Cognitive Dysfunction; Humans; Nootropic Agents; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Stroke; Vinca Alkaloids | 2019 |
2 trial(s) available for vinpocetine and Cognitive Dysfunction
| Article | Year |
|---|---|
Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Cognition; Cognitive Dysfunction; Cytokines; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Inflammation; Male; Mental Status and Dementia Tests; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxidants; Oxidative Stress; Radiation Injuries; Random Allocation; Toll-Like Receptors; Vinca Alkaloids | 2021 |
[Study of the effects of vinpocetin on cognitive functions].
Topics: Administration, Oral; Adult; Aged; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Dementia; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Nootropic Agents; Psychometrics; Quality of Life; Severity of Illness Index; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2012 |
3 other study(ies) available for vinpocetine and Cognitive Dysfunction
| Article | Year |
|---|---|
Vinpocetine and coenzyme Q10 combination alleviates cognitive impairment caused by ionizing radiation by improving mitophagy.
Topics: Adenosine Triphosphate; Animals; Cognitive Dysfunction; Electron Transport Complex I; Mice; Mitophagy; Radiation, Ionizing; Ubiquinone; Vinca Alkaloids | 2022 |
Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats.
Topics: Aluminum; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Cognitive Dysfunction; Glycogen Synthase Kinase 3 beta; Male; Maze Learning; Neuroprotective Agents; Rats; Rats, Wistar; Signal Transduction; Social Isolation; Vinca Alkaloids | 2019 |
[Comment on the paper by A. Valikovics et al. "The effect of vinpocetin on cognitive function" published in the issue 3-4 of this year].
Topics: Cognition; Cognitive Dysfunction; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neuroprotective Agents; Neuropsychological Tests; Nootropic Agents; Periodicals as Topic; Quality of Life; Treatment Outcome; Vinca Alkaloids | 2012 |